Inverness Medical Innovations, a global provider of improving health at home rapid diagnostics and health management, has changed its name to Alere, after the shareholders have approved the name change at its Annual Meeting of Stockholders held on July 14, 2010.
Inverness Medical has earlier filed a preliminary proxy statement with the Securities and Exchange Commission including a proposal to change its name, as well as other proposals, and has filed a definitive proxy statement on June 4, 2010.
Headquartered in Waltham, Massachusetts, Alere (Inverness Medical Innovations) develops new capabilities in near-patient diagnosis, monitoring and health management.
Alere’s global products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Alere is
Ron Zwanziger, CEO of Inverness Medical Innovations, said: “The name Alere, which is derived from Latin and means to nurture, to care for or to support, was selected based on extensive research with investors, customers and industry experts both in the US and abroad.
“We currently utiliSe the Alere brand for our health management services offerings and, therefore, the name already benefits from recognition within the healthcare community by providers and patients alike. The new name is appropriate for a company that sees its foremost task as the continuous improvement of patient care.”